C5076
Cholesteryl myristate
~99% (HPLC; detection at 205 nm)
Synonym(s):
3β-Hydroxy-5-cholestene 3-tetradecanoate, 5-Cholesten-3β-ol 3-tetradecanoate, Cholesteryl tetradecanoate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C41H72O2
CAS Number:
Molecular Weight:
597.01
UNSPSC Code:
12352200
PubChem Substance ID:
EC Number:
217-867-8
MDL number:
assay
~99% (HPLC; detection at 205 nm)
storage temp.
−20°C
SMILES string
CCCCCCCCCCCCCC(=O)OC1CCC2(C)C3CCC4(C)C(CCC4C3CC=C2C1)[C@@H](C)CCCC(C)C
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Friederike Mengersen et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 82(2), 262-271 (2012-07-04)
Supercooled smectic cholesteryl myristate nanoparticle dispersions, a potential carrier system for lipophilic drugs, can be stabilized with phospholipids and their mixtures with sodium glycocholate. Such dispersions are commonly prepared by high-pressure melt homogenization. As cholesterol esters and phospholipids are both
C Burks et al.
Proceedings of the National Academy of Sciences of the United States of America, 78(11), 6863-6867 (1981-11-01)
The possible involvement of cholesteryl ester states in the development and persistence of atherosclerosis and the transport and storage of cholesteryl esters has led to questions concerning the organization and conformation of cholesteryl ester molecules in both pure phases and
J Kuntsche et al.
Colloids and surfaces. B, Biointerfaces, 44(1), 25-35 (2005-07-02)
Supercooled smectic nanoparticles based on physiological cholesterol esters are under investigation as a potential novel carrier system for lipophilic drugs. The present study investigates the very complex crystallization behavior of such nanoparticles stabilized with the aid of phospholipids. Phospholipid and